Endovia Health Sciences EDVA
NYSE EDVA
$0.26 +0.00 (+0.57%)
As of: Sep 3, 2026 · 1:24 PM EDT

Endovia Health Sciences (EDVA) Interest & Investment Income (2012 - 2024)

Analysis

Endovia Health Sciences (EDVA) Interest & Investment Income (2012 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 140.92 Bn 133.07 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 87.02 Bn 79.02 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 64.96 Bn 59.78 Bn 1.37 Bn 48.00 Mn
4 Moderna 57.31 Bn 52.17 Bn 52.00 Mn 67.00 Mn
5 Revolution Medicines 44.60 Bn 44.60 Bn - 35.58 Mn
6 BeOne Medicines 40.49 Bn 35.39 Bn 1.53 Bn 27.90 Mn
7 Alnylam Pharmaceuticals 35.51 Bn 32.21 Bn 992.69 Mn 28.14 Mn
8 Royalty Pharma 28.21 Bn 27.37 Bn - 5.13 Mn
9 Insmed 27.52 Bn 26.36 Bn 358.27 Mn 10.98 Mn
10 Endovia Health Sciences 815,264.74 572,562.74 - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 420.00
Sep 30, 2024 736.00
Jun 30, 2024 503.00
Mar 31, 2024 332.00
Dec 31, 2023 966.00
Sep 30, 2023 348.00
Jun 30, 2023 1,320.00
Dec 31, 2022 3,201.00
Sep 30, 2022 158.00
Jun 30, 2022 2,709.00
Dec 31, 2021 1.00
Sep 30, 2021 527.00
Jun 30, 2021 1.00
Mar 31, 2021 114.00
Dec 31, 2020 -32,702.00
Sep 30, 2020 16,354.00
Jun 30, 2020 205.00
Mar 31, 2020 16,151.00
Dec 31, 2019 -220.00
Sep 30, 2019 320.00